Plying Proteomics Skills for Premium Jobs

A 2001 surge in proteomics investment has generated record revenues, seeding a burgeoning job market and a flowering of training courses and research resources. Proteomics revenues grew 41.9% from $963 million to $1.37 billion (US), in 2001, according to Frost & Sullivan, a San Antonio, Texas-based investment firm. Most of the revenues are from sales of laboratory instruments and supplies, now leaving these fully equipped labs needing to hire staff to use the tools. "We have all this wonderful e

| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

According to Kruip, Aventis seeks people with skills in mass spectrometry and protein and peptide chromatographic separation, but as proteomics continues to evolve, so does the definition of a qualified worker. "Right now there is no such thing as a proteomicist," says David Jensen, scientific recruiter of Search Masters International, Downer's Grove, IL. Jensen and Kruip describe the ideal candidate as one who blends an ability to work with specialized lab equipment with a working knowledge of X-ray crystallography, protein chemistry, and computational chemistry. "[But] it can't be expected for someone to have been trained exclusively in proteomics," Jensen observes.

Some fledgling scientists are jumping ahead by acquiring specific proteomics skills on their own. "I just wanted to expand the NMR [nuclear magnetic resonance] knowledge I had for the structural genomics/proteomics approach," says Daniel Monleon, a postdoc trainee at the Rutgers University center of advanced biotechnology in Piscataway, NJ.

Monleon ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Hal Cohen

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo